Xpert MRSA/SA BC

Life threatening cases of severe sepsis, caused by deadly blood stream infections, continue to be an urgent healthcare concern in hospitals across the U.S. Aggressive management of severe sepsis is crucial to improving outcomes — with timely diagnosis as the critical first step. Cepheid's on-demand Xpert^® MRSA/SA BC test detects the presence of methicillin-resistant S. aureus (MRSA) or S. aureus (SA) in gram positive blood culture bottles in less than one hour.

Runs On: GeneXpert^® System

Blood stream infections are a major healthcare concern

• Severe sepsis strikes 750,000 people annually in the U.S., resulting in mortality rates of up to 50%. MRSA and S. aureus are the causative pathogen in up to 35% of severe sepsis cases
• Current culture-based lab testing methods for gram positive blood culture bottles require an additional 18-48 hours for determination of MRSA or SA
• In the absence of timely diagnostic results, clinicians often employ empiric treatment approaches, using broad-spectrum antimicrobial therapies that can be costly, ineffective and contribute to an increase in drug resistance

On-demand molecular testing — an ideal solution

• One hour positive blood culture bottle results for both MRSA and SA
• Outstanding clinical performance
• Results available around the clock
• Easily integrates into institution septic bundle processes

Critical healthcare benefits in rapid detection

• Allows de-escalation from broad-spectrum therapy to a targeted antimicrobial approach 18-48 hours sooner
• Enhance patient outcomes
• Reduce length of stay
• Improve antimicrobial stewardship and help ensure appropriate
  infection control procedures